Skip to main content
. 2015 Jan 12;33(12):1325–1333. doi: 10.1200/JCO.2014.57.4244

Table A2.

Best Overall Response Rate

Response Cy/GVAX Plus CRS-207 (n = 61)
Cy/GVAX (n = 29)
No. % No. %
CR 0 0 0 0
PR 0 0 0 0
SD 19 31 7 24
PD 31 51 15 52
NE 2 3 1 3
Missing* 9 15 6 21

Abbreviations: CR, complete response; Cy, cyclophosphamide; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.

*

Clinical progression before week-10 response assessment.